ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
6.42
-0.25 (-3.75%)
Feb 20, 2026, 4:00 PM EST - Market closed
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $58.07 million as of February 20, 2026. Its market cap has increased by 22.96% in one year.
Market Cap
58.07M
Enterprise Value
67.79M
1-Year Change
22.96%
Ranking
Category
Stock Price
$6.42
Market Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $58.07M, an increase of 2,815.38%. That is a compound annual growth rate of 10.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 58.07M | 4.39% |
| Dec 31, 2025 | 55.63M | 21.22% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 61.52M |
| Cingulate | 61.36M |
| MindWalk Holdings | 61.17M |
| InflaRx | 60.61M |
| Grace Therapeutics | 60.04M |
| NeurAxis | 58.91M |
| TScan Therapeutics | 57.32M |
| Tevogen Bio Holdings | 56.59M |